Dozens of firms to make cheap version of Merck COVID pill for poorer nations
BRUSSELS, Jan 20 (Reuters) - A U.N.-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost versions of Merck & Co's COVID-19 pill molnupiravir for poorer…